RABBANI ELAZAR 4
4 · ENZO BIOCHEM INC · Filed Jan 4, 2019
Insider Transaction Report
Form 4
RABBANI ELAZAR
DirectorChairman and CEO
Transactions
- Award
Stock Option (to acquire common stock)
2019-01-03+128,000→ 222,249 totalExercise: $2.80From: 2020-01-04Exp: 2024-01-02→ Common Stock (128,000 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted 128,000 stock options. The options have a five-year term and shall vest in two equal annual tranches, beginning January 4, 2020.
- [F2]Does not include 25,000 Restricted Stock Units granted to the Reporting Person on January 3, 2019, which will vest, if at all, based upon (i) achievement of average revenue growth and adjusted EBITDA growth goals on January 3, 2022, and (ii) the continued service of the Reporting Person through January 3, 2022.